{"id":448662,"date":"2026-05-28T01:15:07","date_gmt":"2026-05-28T01:15:07","guid":{"rendered":"https:\/\/www.newsbeep.com\/nz\/448662\/"},"modified":"2026-05-28T01:15:07","modified_gmt":"2026-05-28T01:15:07","slug":"the-latest-biotech-updates-biotechniques","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/nz\/448662\/","title":{"rendered":"The Latest Biotech Updates &#8211; BioTechniques"},"content":{"rendered":"<p>In this week\u2019s biotech bi-weekly, we explore recent product launches, partnerships and publications that have sparked interest in the biotech space, from a new brain organoid assay to presenting the latest lab automation innovations. Products Unveiling a new brain organoid assay 28bio (LA, USA) has announced the launch of the CNS-3D Induced Alzheimer&#8217;s Model, a brain organoid assay enabling researchers to evaluate whether therapeutic candidates can reduce or prevent disease progression in patients. The CNS-3D Induced Alzheimer&#8217;s Model includes human neuroimmune organoids and exogeneous amyloid beta oligomers to evaluate Alzheimer&#8217;s-relevant phenotypes. This assay-ready solution enables researchers to reproduce complex neuroimmune&#8230;<\/p>\n<p>\tTo view this content, please register now for access<\/p>\n<p>Join our member community for FREE to access a collection of journal and online-only features, including:<\/p>\n<p>\t\tExclusive access to educational videos, eBooks and insights into top BioTechniques journal articles<br \/>\n\t\tThe latest news and journal updates delivered straight to your inbox when you want it<br \/>\n\t\tPersonalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions<br \/>\n\t\tPriority registration to webinars, panel discussions and events<br \/>\n\t\tAccess to competitions and journal publication discounts, including 10% off open access fees when you sign up today!<\/p>\n","protected":false},"excerpt":{"rendered":"In this week\u2019s biotech bi-weekly, we explore recent product launches, partnerships and publications that have sparked interest in&hellip;\n","protected":false},"author":2,"featured_media":448663,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[192525,134,228613,111,139,69],"class_list":["post-448662","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-biotech-industry","tag-health","tag-industry-updates","tag-new-zealand","tag-newzealand","tag-nz"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/448662","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/comments?post=448662"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/448662\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media\/448663"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media?parent=448662"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/categories?post=448662"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/tags?post=448662"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}